5-hydroxytryptamine receptor 2B — Drug Target
All drugs that target 5-hydroxytryptamine receptor 2B — marketed and clinical-stage. Includes 6 drug classes acting on this target.
Drug classes
Antiarrhythmic · General Anesthetic [EPC] · Serotonin-4 Receptor Agonist · chloroxylenol · nalidixic acid · aclarubicin
Marketed (5)
- Mexitil · Boehringer Ingelheim · Antiarrhythmic · Metabolic
Mexitil works by blocking abnormal electrical signals in the heart to restore a normal heartbeat. - Forane · Baxter · General Anesthetic [EPC] · Neuroscience
- Zelnorm · Serotonin-4 Receptor Agonist · Metabolic
- Benzytol · chloroxylenol · Metabolic
- Nalidixate · nalidixic acid · Infectious Disease
Phase 3 pipeline (1)
- Aclacur · aclarubicin · Oncology
Aclacur works by binding to the 5-hydroxytryptamine receptor 2B, which is involved in cell growth and proliferation.